Patents
Patents for C07C 335 - Thioureas, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (3,175)
08/2004
08/05/2004US20040152741 Arylglycine derivatives and their use as glycine transport inhibitors
08/05/2004US20040152740 Central nervous system disorders; psychological disorders; analgesics
07/2004
07/29/2004WO2004062601A2 Antibacterial agents
07/29/2004WO2004046091A3 Biaromatic compounds which activate ppar-gama type receptors, and use thereof in cosmetic or pharmaceutical compositions
07/29/2004US20040147569 Cell differentiation inducer
07/29/2004CA2851462A1 Antibacterial agents
07/29/2004CA2512582A1 Antibacterial agents
07/28/2004EP1137632B1 Thiourea inhibitors of herpes viruses
07/22/2004US20040142877 Ligands of the $g(a)v$g(b)6 integrin
07/15/2004WO2004058709A1 Ccr8 inhibitors
07/15/2004WO2004058683A2 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
07/15/2004WO2004035736A3 Halogenated selective androgen receptor modulators and methods of use thereof
07/15/2004US20040138205 Viricides; hepatitis virus
07/14/2004EP1437346A1 Benzamide derivatives useful as cell differentiation inducers
07/14/2004EP1436256A1 Preparation process of some halogeno-substituted monosulfides and their hydroxy-monosulfide or isothiouronium bromide equivalents as intermediates
07/08/2004WO2002034203A3 Novel derivatives of phenyl 4-aminosalicylate and method of making the same
06/2004
06/30/2004EP1433778A1 Use of nitriles as rotamase inhibitors
06/30/2004CN1155562C New naphthalene compounds, process for their preparation and pharmaceutical compositions containing them
06/24/2004US20040122089 Analogs of andandamide and arvanil have been found to act at receptors; are useful in pain management, used as anti-proliferative/anti-tumor agents, vasodilators, and in other applications
06/23/2004EP1430024A1 Alkyl urea retinoid agonists i
06/23/2004EP1430023A1 Substituied urea retinoid agonists ii
06/17/2004WO2004050612A1 S-substituted n-1-[(hetero)aryl]alkyl-n′-[(hetero)aryl] alkylysothiocarbamides, method for the production thereof, physiologically active s-substituted n-1-[(hetero)aryl]alkyl-n′-[(hetero)aryl]alkylysothiocarbamides, a pharmaceutical compound and curing method
06/17/2004CA2508783A1 S-substituted n-1-¬(hetero) aryl|alkyl-n'-¬(hetero)aryl|alkylisothiocarbamides, a method for the preparation of these, physiologically active s-substituted n-1-¬(hetero)aryl|alkyl-n'-¬(hetero)aryl|alkylisothiocarbamides, a pharmaceutical composition and method of treatment
06/10/2004US20040110830 20-hydroxyeicosatetraenoic acid (HETE); useful as therapeutic agents for kidney diseases, cerebrovascular diseases, or circulatory diseases
06/10/2004US20040110801 Prevention of degenerative joint diseases, rheumatoid arthritis, osteoarthritis, ulcerative colitis, irritable colon and Crohn's diseas, antitumor agents; drug mixture for transdermal drug delivery, sustained release; chemical synthesis
06/03/2004WO2004046095A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication
06/03/2004WO2004046091A2 Biaromatic compounds which activate ppar-gama type receptors, and use thereof in cosmetic or pharmaceutical compositions
06/03/2004US20040106829 reaction of benzhydryl chloride with thiourea and chloroacetamide to prepare 2-(benzhydrylthio)acetamide (II), key intermediate for the synthesis of modafinil
06/03/2004US20040106792 Biphenyl compound
06/03/2004CA2506415A1 Substituted aryl thioureas and releated compounds; inhibitors of viral replication
06/02/2004EP1423356A2 Novel aminobenzoephenones
06/02/2004CN1501827A Ligands of the alpha-v-beta 6 integrin
06/01/2004US6743877 Electrode materials derived from polyquinonic ionic compounds and their use in electrochemical generators
05/2004
05/27/2004US20040102521 Excitatory amino acid receptor modulators
05/27/2004US20040102513 2'-Substituted 1,1'-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
05/26/2004EP1137645B1 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
05/26/2004CN1151124C Process for preparing N,N'-diphenyl sulfourea
05/21/2004WO2004022528A3 Arylglycine derivatives and their use as glycine transport inhibitors
05/20/2004US20040097755 Ionic liquids and their use as solvents
05/20/2004US20040097589 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
05/06/2004US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics
04/2004
04/29/2004WO2004035736A2 Halogenated selective androgen receptor modulators and methods of use thereof
04/29/2004WO2004035533A1 Novel n-hydroxy thiourea, urea and amide compounds and the pharmaceutical compositions comprising the same
04/29/2004US20040083060 Method of operating a computer system to perform a discrete substructural analysis
04/29/2004CA2588083A1 Selective androgen receptor modulators and methods of use thereof
04/29/2004CA2502527A1 Novel n-hydroxy thiourea, urea and amide compounds and the pharmaceutical compositions comprising the same
04/29/2004CA2502355A1 Halogenated selective androgen receptor modulators and methods of use thereof
04/28/2004CN1493051A Method for operating a computer system to perform discrete substructural analysis
04/20/2004US6723751 Individual polymorphic forms of crystalline sodium salt having specified x-ray diffraction spectra
04/20/2004CA2215585C Practical synthesis of urea derivatives
04/15/2004US20040073054 Using a fluorinated phenyl compound containing electrophilic and nucleophilic groups
04/15/2004US20040073037 Anticholesterol agents; cardiovascular disorders; antiinflammatory agents; peroxisome proliferator activator receptor antagonist
04/08/2004WO2003027064B1 Simplified resiniferatoxin analogues as vanilloid receptor agonist showing excellent analgesic activity and the pharmaceutical co mpositions containing the same
04/01/2004WO2004026815A2 Phenol derivatives and their use as rotamase inhibitors
04/01/2004WO2003057792A3 Composition containing a polymerizable reducing agent, kit, and method
04/01/2004US20040063786 Simplified resiniferatoxin analogues as vanilloid receptor agonist showing excellent analgesic activity and the pharmaceutical compositions containing the same
04/01/2004US20040063671 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
04/01/2004US20040061039 Furnace mount and method of installation
04/01/2004CA2498662A1 Phenol derivatives and their use as rotamase inhibitors
03/2004
03/31/2004EP1402888A1 The use of substituted carbocyclic compounds as rotamases inhibitors
03/31/2004EP0770065B1 Tri-substituted phenyl derivates useful as pde iv inhibitors
03/31/2004CN1486302A Abca-1 elevating compounds against coronary artery disease or atherosclerosis
03/30/2004US6713650 ABCA-1 elevating compounds
03/23/2004US6709824 Screening sample for catalyst; generate library of catalyst, screen library, recover catalyst
03/18/2004WO2004022534A1 Arylglycine derivatives for use as glycine transport inhibitors
03/18/2004WO2004022528A2 Arylglycine derivatives and their use as glycine transport inhibitors
03/18/2004WO2003018535A3 Novel aminobenzoephenones
03/17/2004EP1140810B1 Benzenic sulphonamide derivatives and their uses
03/17/2004EP0966769B1 Novel electrode materials derived from polyquinoid ionic compounds and their uses in electrochemical generators
03/11/2004US20040048834 Antitumoral compounds
03/10/2004EP1395548A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments
03/10/2004EP1084101B1 New 3-aryl-2-hydroxypropionic acid derivative iii
03/04/2004US20040044049 Compounds for inhibiting insulin secretion and methods related thereto
03/04/2004US20040043426 Using "tethering" where potential ligands are covalently bonded or "tethered" to a target and subsequently identified
03/03/2004EP1392655A2 Potassium channel openers
03/03/2004EP1392280A2 Arylsulfonamide ethers, and methods of use thereof
03/03/2004CN1140498C Novel antiarrhythmic compounds
02/2004
02/26/2004US20040038934 Preparation from bis2-(N'-ethylcarbodimido)ethyldisulfide, hyaluronic acid and a reducing agent; useful in ophthalmic surgery and in tissue engineering.
02/25/2004EP1390345A1 Polythiourea lipid derivatives
02/25/2004EP1073629B1 Anion-complexing compound, method of preparing the same, an ion-selective membrane and a sensor provided with such a compound or membrane
02/25/2004EP1005446B1 N-aroylphenylalanine derivatives
02/25/2004CN1478085A ABCA-1 elevating compounds against coronary artery disease or atherosclerosis
02/24/2004US6696487 Fungicidal phenyl(thio)urea and phenyl(thio)carbamate derivatives
02/24/2004US6696475 Substituted phenyl derivatives, their preparation and use
02/19/2004US20040034069 Nitrogen-containing compounds and their use as glycine transport inhibitors
02/18/2004EP1169301B1 A topical antiandrogen for hair loss and other hyperandrogenic conditions
02/12/2004US20040030188 3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same
02/12/2004US20040029928 Tumor necrosis factor alpha-converting enzyme inhibitor; rheumatic diseases; antiarthritic agents; infections; autoimmune diseases; antidiabetic agents
02/12/2004US20040029913 Halogenated selective androgen receptor modulators and methods of use thereof
02/11/2004EP1387831A1 Substituted arylketones
02/05/2004WO2003095396A3 N,n,-substituted s-aryl-isothioureas, n,n,n'-substituted s-aryl-isothioureas and combinatorial libraries thereof
02/05/2004US20040023290 Novel therapeutic agents that modulate enzymatic processes
02/04/2004CN1137121C Process for preparation of 2-aminothiazolecarboxamide derivatives
02/03/2004US6686395 2′-substituted 1,1′-biphenyl-2-carboxamides, process for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
01/2004
01/29/2004WO2003066035A3 Compounds for inhibiting insulin secretion and methods related thereto
01/28/2004CN1471509A 9-substituted minocycline compounds
01/27/2004US6683201 Analine derivatives as OSC inhibitors
01/22/2004WO2004007407A2 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
01/21/2004EP1381593A2 (2-hydroxy)ethyl-thioureas useful as modulators of alpha2b adrenergic receptors
01/21/2004EP1381360A1 Compounds and methods for inhibiting metap2 in mammals
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 32